NL-OMON39006已完成3 期
MEA115661: A multi-centre, open-label, long-term safety study of mepolizumab in asthmatic subjects who participated in the MEA115588 or MEA115575 trials - MEA115661
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Completion of the double-blind treatment during MEA115588 or MEA115575.
- •* Current treatment with an additional controller medication for the past 12 weeks.
- •* Adequate contraception during the study and the following 4 months for females of childbearing potential.
排除标准
- •* A study related SAE in MEA115588 or MEA115575 that was assessed as possibly related to study medication by the investigator
- •* Pregnancy or breastfeeding
- •* Current smokers.
- •* Baseline ECG which has a clinically significant abnormality or which shows QTcF prolongation.
研究者
相似试验
进行中（未招募）
不适用
A safety study for subjects with severe asthma who participated in MEA115575 or MEA115588Subjects with Severe AsthmaMedDRA version: 16.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-001644-21-GBGlaxoSmithKline Research & Development Ltd651
进行中（未招募）
不适用
A safety study for subjects with severe asthma who participated in MEA115575 or MEA115588Subjects with Severe AsthmaEUCTR2012-001644-21-NLGlaxoSmithKline Research & Development Ltd660
进行中（未招募）
不适用
A safety study for subjects with severe asthma who participated in MEA115575 or MEA115588Subjects with Severe AsthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-001644-21-DEGlaxoSmithKline Research & Development Ltd651
进行中（未招募）
不适用
A safety study for subjects with severe asthma who participated in MEA115575 or MEA115588Subjects with Severe Asthma.MedDRA version: 15.1Level: LLTClassification code 10068462Term: Eosinophilic asthmaSystem Organ Class: 100000004855EUCTR2012-001644-21-ESGlaxoSmithKline, S.A.660
进行中（未招募）
不适用
A safety study for subjects with severe asthma who participated in MEA115575 or MEA115588EUCTR2012-001644-21-CZGlaxoSmithKline Research & Development Ltd651